Long-term outcome of newly diagnosed epilepsy
|Professor Patrick Kwanemail@example.com||+61 3 9342 7722|
Seventy million people have epilepsy with 34–76 per 100,000 developing the condition every year. To formulate rational treatment plans, it is important to understand the different clinical courses and patterns of response to antiepileptic drugs, ideally by following outcomes from the point of treatment initiation.
This project will perform analysis focusing on response to the initial therapies and their relationship with long-term treatment outcomes and development of pharmacoresistance in newly treated epilepsy patients. The student will be involved in recruiting and following up eligible patients. Basic knowledge and skills in biostatistics is preferred.
Faculty Research Themes
School Research Themes
For further information about this research, please contact the research group leader.